Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
Standard
Baseline prevalence of erectile dysfunction in a prostate cancer screening population. / Walz, Jochen; Perrotte, Paul; Suardi, Nazareno; Hutterer, Georg; Jeldres, Claudio; Bénard, Francois; Valiquette, Luc; Graefen, Markus; Montorsi, Francesco; Karakiewicz, Pierre I.
In: J SEX MED, Vol. 5, No. 2, 2, 2008, p. 428-435.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
AU - Walz, Jochen
AU - Perrotte, Paul
AU - Suardi, Nazareno
AU - Hutterer, Georg
AU - Jeldres, Claudio
AU - Bénard, Francois
AU - Valiquette, Luc
AU - Graefen, Markus
AU - Montorsi, Francesco
AU - Karakiewicz, Pierre I
PY - 2008
Y1 - 2008
N2 - INTRODUCTION: Erectile dysfunction (ED) is common in older men and can be worsened by prostate cancer (PCa) treatment. True ED rates before PCa treatment are mandatory, in order to assess the rate of ED attributable to PCa treatment. Data derived from population-based studies or from patients surveyed after PCa diagnosis, as well as just prior to treatment may not represent a valid benchmark, as health profiles of the general population might be different to those undergoing PCa screening or as anxiety may worsen existent ED. AIM: To circumvent these limitations, we assessed the baseline rate of ED in PCa diagnosis-free men participating in a PCa awareness event. METHODS: ED was classified according to the International Index of Erectile Function (IIEF) score as absent (IIEF: 25-30), mild (22-24), mild to moderate (17-21), moderate (11-16), or severe (
AB - INTRODUCTION: Erectile dysfunction (ED) is common in older men and can be worsened by prostate cancer (PCa) treatment. True ED rates before PCa treatment are mandatory, in order to assess the rate of ED attributable to PCa treatment. Data derived from population-based studies or from patients surveyed after PCa diagnosis, as well as just prior to treatment may not represent a valid benchmark, as health profiles of the general population might be different to those undergoing PCa screening or as anxiety may worsen existent ED. AIM: To circumvent these limitations, we assessed the baseline rate of ED in PCa diagnosis-free men participating in a PCa awareness event. METHODS: ED was classified according to the International Index of Erectile Function (IIEF) score as absent (IIEF: 25-30), mild (22-24), mild to moderate (17-21), moderate (11-16), or severe (
M3 - SCORING: Zeitschriftenaufsatz
VL - 5
SP - 428
EP - 435
JO - J SEX MED
JF - J SEX MED
SN - 1743-6095
IS - 2
M1 - 2
ER -
